Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women?s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men?s and women?s health, and prostate health. The company?s products also inc
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||-1.55%||Sales Growth - 4 Quarters||-15.23%||Sales Growth - Q/Q||-10.73%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-2.55%||ROE||-8.7%||ROI||-3.62%|
|Current Ratio||1.55||Quick Ratio||1.37||Long Term Debt/Equity||2.86||Debt Ratio||0.83|
|Gross Margin||49.62%||Operating Margin||-27.98%||Net Profit Margin||-11.54%||Dividend Payout Ratio|
|Cash From Financing Activities||Cash From Investing Activities||996.86 M||Cash From Operating Activities||-930.48 M||Gross Profit||329.86 M|
|Net Profit||-89.81 M||Operating Profit||45.75 M||Total Assets||14.15 B||Total Current Assets||5.33 B|
|Total Current Liabilities||3.44 B||Total Debt||5.39 B||Total Liabilities||10.01 B||Total Revenue||714.13 M|
|High 52 week||18.3||Low 52 week||2.23||Last close||3.49||Last change||3.87%|
|RSI||56.72||Average true range||0.35||Beta||0.74||Volume||2.59 M|
|Simple moving average 20 days||0.37%||Simple moving average 50 days||12.06%||Simple moving average 200 days||-43.02%|
|Performance Week||-6.43%||Performance Month||-16.9%||Performance Quart||-0.29%||Performance Half||-53.59%|
|Performance Year||-80.07%||Performance Year-to-date||-52.19%||Volatility daily||6.16%||Volatility weekly||13.76%|
|Volatility monthly||28.21%||Volatility yearly||97.72%||Relative Volume||179.67%||Average Volume||7.95 M|
|New High||New Low|
2020-05-27 12:56:10 | John Paulson Adds 2 Stocks to Portfolio, Boosts Tiffany
2020-05-14 17:00:00 | Endo to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference
2020-05-14 07:38:00 | Endo International plc Announces Proposed Exchange Offers And Consent Solicitations
2020-05-13 10:05:23 | Was The Smart Money Right About Endo International plc ENDP?
2020-05-08 12:01:56 | Endo International ENDP Q1 2020 Earnings Call Transcript
2020-05-08 10:26:02 | Endo ENDP Q1 Earnings Beat on Coronavirus-Led Stockpiling
2020-05-07 19:11:58 | Edited Transcript of ENDP earnings conference call or presentation 7-May-20 12:00pm GMT
2020-05-07 15:11:00 | Endo International Fires on All Cylinders in Q1 Thanks to COVID-19 Impact
2020-05-07 09:53:18 | Endo International: Q1 Earnings Insights
2020-05-07 09:15:01 | Endo International ENDP Q1 Earnings and Revenues Top Estimates
2020-05-01 09:26:00 | Will an Opioid Manufacturer Stage a Comeback With This New Venture?
2020-04-30 12:33:04 | Endo International ENDP Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-04-16 17:00:00 | Endo to Announce First Quarter 2020 Financial Results
2020-04-14 12:10:04 | Why the Earnings Surprise Streak Could Continue for Endo ENDP
2020-04-07 09:46:00 | Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes
2020-03-27 18:45:21 | Covid-19 Could Benefit Generic Drug Companies
2020-03-27 11:30:03 | Why Is Endo ENDP Down 33% Since Last Earnings Report?
2020-03-19 10:03:00 | The Coronavirus Outbreak Has Derailed Settlements in the Opioid Litigation
2020-03-06 10:06:03 | Implied Volatility Surging for Endo International ENDP Stock Options
2020-03-03 09:00:28 | These 3 Biotech Stocks Are Outperforming Their Peers — Here's Why
2020-03-02 08:26:24 | Does Market Volatility Impact Endo International plc's NASDAQ:ENDP Share Price?
2020-02-27 15:15:08 | Endo's ENDP Earnings & Revenues Trump Estimates in Q4
2020-02-26 23:44:40 | Edited Transcript of ENDP earnings conference call or presentation 26-Feb-20 1:00pm GMT
2020-02-26 07:35:12 | Endo International ENDP Q4 Earnings and Revenues Top Estimates
2020-02-26 06:08:44 | Drugmaker Endo posts smaller loss on asset impairment charges
2020-02-26 06:00:00 | Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results
2020-02-26 06:00:00 | Endo International plc to Host Earnings Call
2020-02-20 13:26:44 | Endo International chooses a familiar face to be new CEO
2020-02-19 16:20:00 | Endo Names Blaise Coleman President and Chief Executive Officer
2020-02-19 16:20:00 | Endo Appoints Mark G. Barberio to Board of Directors
2020-02-19 12:31:05 | Earnings Preview: Endo International ENDP Q4 Earnings Expected to Decline
2020-02-12 10:55:30 | Small-Cap Healthcare ETF Outperforming in 2020: 5 Top Stocks
2020-01-27 17:20:10 | Here's Why You Should Add BioDelivery Stock to Your Portfolio
2020-01-24 17:00:00 | Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results
2020-01-20 08:17:01 | J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge
2020-01-14 12:00:00 | Endo reaches $8.75M opioid settlement with Oklahoma
2020-01-13 09:11:02 | Endo Up on Opioid Abuse Settlement Agreement With Oklahoma
2020-01-10 15:09:00 | Endo settles opioid suit with Oklahoma AG
2020-01-10 11:50:00 | Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million
2019-12-30 09:12:02 | Will J&J be Able to Overcome Its Legal Troubles in 2020?
2019-12-20 08:40:01 | Implied Volatility Surging for Endo ENDP Stock Options
2019-12-17 17:00:00 | Endo to Participate at J.P. Morgan Healthcare Conference
2019-12-10 08:06:00 | Endo Launches Generic Version of Afinitor® everolimus Tablets in the United States
2019-12-09 13:08:43 | Did Hedge Funds Drop The Ball On Endo International plc ENDP ?
2019-12-04 11:30:04 | Why Is Endo ENDP Up 12.3% Since Last Earnings Report?
2019-12-04 08:54:01 | Options Traders Expect Huge Moves in Endo ENDP Stock